Loading…

DexCom announced the acquisition of TypeZero Technologies, a developer of algorithms for automated insulin delivery systems. Terms were not disclosed. DexCom expects to support the first commercial launch of an AID system using TypeZero's algorithm in 2019.
“DexCom announced last week the acquisition of TypeZero Technologies, a developer of algorithms that manage automated insulin delivery (AID) for people with diabetes.”medtechdive.com
Summarized from public sources; check the original articles before acting on it.